Zacks Investment Research Lowers U.S. Physical Therapy, Inc. (USPH) to Hold
Zacks Investment Research downgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a buy rating to a hold rating in a research report report published on Saturday morning.
According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “
Several other brokerages have also issued reports on USPH. Barrington Research raised U.S. Physical Therapy from a market perform rating to an outperform rating and set a $68.00 price objective on the stock in a report on Monday, July 3rd. Jefferies Group LLC reaffirmed a hold rating and set a $63.00 price objective on shares of U.S. Physical Therapy in a report on Friday, June 30th. Cantor Fitzgerald initiated coverage on U.S. Physical Therapy in a report on Monday, July 24th. They set an overweight rating and a $72.00 price objective on the stock. Finally, BidaskClub lowered U.S. Physical Therapy from a sell rating to a strong sell rating in a report on Sunday, July 16th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $68.50.
U.S. Physical Therapy (NYSE USPH) opened at 57.65 on Friday. The stock has a market capitalization of $725.29 million, a PE ratio of 36.49 and a beta of 1.06. The stock’s 50 day moving average price is $61.76 and its 200 day moving average price is $65.33. U.S. Physical Therapy has a 1-year low of $51.96 and a 1-year high of $78.00.
U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.60 by $0.01. The business had revenue of $104.25 million during the quarter, compared to analysts’ expectations of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. On average, equities research analysts predict that U.S. Physical Therapy will post $2.13 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Monday, August 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, August 17th. This represents a $0.80 annualized dividend and a dividend yield of 1.39%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 46.78%.
In related news, Director Bernard A. Harris, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $62.00, for a total value of $310,000.00. Following the completion of the sale, the director now owns 26,422 shares in the company, valued at $1,638,164. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Glenn Mcdowell sold 1,664 shares of the firm’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $59.91, for a total transaction of $99,690.24. The disclosure for this sale can be found here. Insiders have sold 9,664 shares of company stock valued at $595,810 in the last quarter. Insiders own 3.10% of the company’s stock.
Large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in shares of U.S. Physical Therapy by 166,319.0% in the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock worth $101,501,000 after buying an additional 1,553,419 shares during the last quarter. Aberdeen Asset Management PLC UK increased its stake in shares of U.S. Physical Therapy by 13.4% in the second quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock worth $42,582,000 after buying an additional 83,253 shares during the last quarter. Renaissance Technologies LLC increased its stake in shares of U.S. Physical Therapy by 10.4% in the second quarter. Renaissance Technologies LLC now owns 668,074 shares of the company’s stock worth $40,352,000 after buying an additional 63,074 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of U.S. Physical Therapy by 6.5% in the first quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock worth $41,892,000 after buying an additional 39,290 shares during the last quarter. Finally, Bridge City Capital LLC purchased a new stake in shares of U.S. Physical Therapy during the second quarter worth approximately $1,760,000. Hedge funds and other institutional investors own 95.50% of the company’s stock.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.